Pulmonary involvement in polymyositis and dermatomyositis;Atteintes pulmonaires des polymyosites et dermatopolymyosites

Revue des Maladies Respiratoires

Volumn 23, Issue 6, 2006, Pages 671-680

  Tillie Leblond, I ^a   Colin, G ^a   Lelong, J ^a   Cadranel, J ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b HÔPITAL TENON   (France)

Author keywords

Interstitial lung disease; Lung; Myositis

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; SYNTHETASE;

ACUTE RESPIRATORY FAILURE; ARTICLE; CHRONIC RESPIRATORY FAILURE; CLINICAL FEATURE; DERMATOMYOSITIS; DIAPHRAGM MUSCLE; HUMAN; HYPERCAPNIA; INTERSTITIAL PNEUMONIA; POLYMYOSITIS; PROGNOSIS; PULMONARY HYPERTENSION; SWALLOWING;

EID: 33846142181     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0761-8425(06)72081-2     Document Type: Article

References (74)

1. Arsura EL, Greenberg AS : Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatopolymyositis. Semin Arthritis Rheum 1988 ; 18 : 29-37.
2. Marguerie C, Bunn CC, Beynon HLC, Bernstein RM, Hughes JMB, So AK, Walport MJ : Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthase enzymes. Q J Med 1990 ; 282 : 1019-38.
3. Schnabel A, Reuter M, Biederer J, Richter C, Gross WL : Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum 2003 ; 32 : 273-84.
4. Schwartz MI : The lung in polymyositis. Clin Chest Medicine 1998 ; 19 : 701-12.
5. Dalakas MC : Muscle biopsy findings in inflammatory myopathies. Rheum Dis Clin N Am 2002 ; 28 : 779-98.
6. Dalakas MC : Polymyositis and dermatomyositis. Lancet 2003 ; 362: 971-82.
7. Callen JP : Dermatomyositis. Lancet 2000 ; 355 : 53-7.
8. Hill CL, Zhang Y, Sigurgeirsson B : Frequency of specific cancer types in dermatomyositis or polymyositis : a population-based study. Lancet 2001 ; 357 : 96-100.
9. Brouwer R, Hengstman GJ, Vree Egberts W, Ehrfeld H, Bozic B, Ghirardello A, Grondal G, Hietarinta M, Isenberg D, Kalden JR, Lundberg I, Moutsopoulos H, Roux-Lombard P, Vencovsky J, Wikman A, Seelig HP, van Engelen BG, van Venrooij WJ : Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 2001 ; 60 : 116-23.
10. Hengstman GJ, van Engelen BG, van Venrooij WJ : Myositis-specific autoantibodies: changing insights in pathophysiology and clinical associations. Curr Opin Rheumatol 2004 ; 16 : 692-9.
11. Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senecal JL : Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore) 2005 ; 84 : 231-49.
12. Medsger TA Jr, Robinson H, Masi AT : Factors affecting survivorship in polymyositis. A life-table study of 124 patients. Arthritis Rheum 1971 ; 14 : 249-58.
13. Teixeira A, Cherin P, Demoule A, Levy-Soussan M, Straus C, Verin E, Zelter M,Derenne JP, Herson S, Similowski T : Diaphragmatic dysfunction in patients with idiopathic inflammatory myopathies. Neuromuscul Disord 2005 ; 15 : 32-9.
14. Blumberg PE, Byrne E, Kakulas BA : polymyositis presenting with respiratory failure. J Neurol Sci 1989 ; 65 : 221-9.
15. Rowen AJ, Reichel J : Dermatomyositis with lung involvement, successfully treated with azathioprine. Respiration 1983 ; 44 : 143-6.
16. Bunch TW, Tancredi RG, Lie JT : Pulmonary hypertension in polymyositis. Chest 1981 ; 79 : 105-7.
17. Grateau G, Roux ME, Franck N, Bachmeyer C, Taulera O, Forest M, Cremer GA, Sereni D : Pulmonary hypertension in a case of dermatomyositis. J Rheumatol 1993 ; 20 : 1452-3.
18. Bull TM, Fagan KA, Badesch DB : Pulmonary vascular manifestations of mixed connective tissue disease. Rheum Dis Clin North Am 2005 ; 31 : 451-64.
19. Yaqub S, Moder KG, Lacy MQ : Severe, reversible pulmonary hypertension in a patient with monoclonal gammopathy and features of dermatomyositis. Mayo Clin Proc 2004 ; 79 : 687-9.
20. Galie N, Manes A, Farahani KV, Pelino F, Palazzini M, Negro L, Romanazzi S, Branzi A : Pulmonary arterial hypertension associated to connective tissue diseases. Lupus 2005 ; 14 : 713-7.
21. Mariette X, Brenot F, Brouet JC : Recovery from pulmonary hypertension with steroid therapy in a patient with Sjogren's syndrome and polymyositis. J Rheumatol 1994 ; 21 : 772-3.
22. Burton FD, Myers AR : Pulmonary disease in polymyositis/dermatomyositis. Semin Arthritis Rheum 1984 ; 14 : 60-76.
23. Cottin V, Thivolet-Bejui F, Reynaud-Gaubert M, Cadranel J, Delaval P, Ternamian PJ, Cordier JF; Groupe d'Etudes et de Recherche sur les Maladies «Orphelines» Pulmonaires : Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis Eur Respir J 2003 ; 22 : 245-50.
24. Douglas WW, Tazelaar HD, Hartman TE, Hartman RP, Decker PA, Schroeder DR, Ryu JH : Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001 ; 164 : 1182-5.
25. Fathi M, Dastmalchi M, Rasmussen E, Lundberg IE, Tornling G : Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 2004 ; 63 : 297-301.
26. Flammang d'ortho MP, Cadranel J, Milleron B, Zalcman G, Arvin-Berod C, Terrioux P, Akoun G : Atteintes pulmonaires interstitielle des polymyosites et dermatopolymyosites. Rev Pneumol Clin 1991, 47 : 29-36.
27. Frazier AR, Miller RD: Interstitial pneumonitis in association with polymyositis and dermatomyositis. Chest 1974 ; 65 : 403-7.
28. Lakhanpal S, Lie JT, Conn DL, Martin WJ : Pulmonary disease in polymyositis and dermatomyositis : a clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis 1987 ; 46 : 23-9.
29. Marie I, Hachulla E, Cherin P, Dominique S, Hatron PY, Hellot MF, Devulder B, Herson S, Levesque H, Courtois H : Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 2002 ; 47 : 614-22.
30. Mills ES, Matthew WH: Interstitial pneumonitis in dermatomyositis. JAMA 1956 ; 160 : 1467-70.
31. Takizawa H, Shiga J, Moroi Y, Miyashi S, Nishiwaki M, Miyamoto T : Interstitial lung disease in dermatomyositis : clinicopathological study. J Rheumatol 1987 ; 14 : 102-7.
32. Marie I, Hachulla E, Hatron PY : Polymyositis and dermatomyositis : short term and longterm outcome, and predictive factors of prognosis. J Rheumatol 2001 ; 28 : 2230-37.
33. Grau JM, Miro O, Pedrol E, Casademont J, Masanes F, Herrero C, Haussman G, Urbano-Marquez A : Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement. J Rheumatol 1996 ; 23 : 1921-6.
34. Bernstein RM, Morgan SH, Chapman J, Bunn CC, Mathews MB, Turner-Warwick M, Hughes GR : Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br Med J (Clin Res Ed) 1984 ; 289 : 151-2.
35. Hochberg MC, Feldman D, Stevens MB, Arnett FC, Reichlin M : Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease. J Rheumatol 1984 ; 11 : 663-5.
36. Love LA, Leff R, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW : A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991 ; 70 : 360-74.
37. Nash P, Schrieber L, Webb J : Interstitial lung disease as the presentation of the anti-Jo-1 positive polymyositis. Clin Rheumatol 1987 ; 6 : 282-6.
38. Schmidt WA, Wetzel W, Friedlander R, Lange R, Sorensen HF, Lichey HJ, Genth E, Mierau R, Gromnica-Ihle E : Clinical and serological aspects of patients with anti-Jo-1 antibodies - an evolving spectrum of disease manifestations. Clin Rheumatol 2000 ; 19 : 371-7.
39. Spath M, Schroder M, Schlotter-Weigel B, Walter MC, Hautmann H, Leinsinger G, Pongratz D, Muller-Felber W : The long-term outcome of anti-Jo-1-positive inflammatory myopathies. J Neurol 2004 ; 251: 859-64.
40. Targoff IN, Trie EP, Plotz PH, Miller FW : Antibodies to glycyl-transfer RNA synthetase in patients with polymyositis and interstitial lung disease. Arthritis Rheum 1992 ; 35 : 821-30.
41. Yoshida S, Akizuki M, Mimori T, Yamagata H, Inada S, Homma M : The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum 1983 ; 26 : 604-11.
42. Arnett FC, Hirsch TJ, Bias WB, Nishikai M, Reichlin M : The Jo-1 antibody system in myositis: relationships to clinical features and HLA. J Rheumatol 1981 ; 8 : 925-30.
43. Mathews MB, Bernstein RM : Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature 1983 ; 304 : 177-9.
44. Nishikai M, Reichlin M : Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum 1980 ; 23 : 881-8.
45. Bergoin C, Buré M, Tavernier JY, Lamblin C, Maurage CA, Rémy-Jardin M, Wallaert B : Le syndrome des anti-synthétases. Rev Mal Respir 2002 ; 19 : 371-4.
46. Schwartz MI, Matthay RA, Sahn SA, Stanford RE, Marmorstein BL, Scheinhorn DJ : Interstitial lung disease in polymyositis and dermatomyositis : analysis of six cases and review of the literature. Medicine 1976 ; 55 : 89-104.
47. Clawson K, OddisC : Adult respiratory distress syndrome in polymyositis patients with the anti Jo-1 antibody. Arthritis Rheum 1995 ; 38 : 1519-23.
48. Ito M, Kaise S, Suzuki S, Kazuta Y, Sato Y, Miyata M, Nishimaki T, Nakamura N, Kasukawa R : Clinico-laboratory characteristics of patients with dermatomyositis accompanied by rapidly progressive interstitial lung disease. Clin Rheumatol 1999 ; 18 : 462-7.
49. Kashiwabara K, Ota K : Rapidly progressive interstitial lung disease in a dermatomyositis patient with high levels of creatine phosphokinase, severe muscle symptoms and positive anti-Jo-1 antibody. Intern Med 2002 ; 41 : 584-8.
50. Chan WM, Ip M, Lau CS : Anti-Jo1 syndrome presenting as cryptogenic organizing pneumonia. Respir Med 1995 ; 89 : 639-41.
51. Friedman AW, Targoff IN, Arnett FC : Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum 1996 ; 26 : 459-67.
52. Kinebuchi S, Mizuno K, Moriyama H, Ooi H, Hasegawa T, Yoshizawa H, Suzuki E, Gejyo F : Two cases of interstitial pneumonia with anti-Jo-1 antibodies in the absence of myositis. Nihon Kokyuki Gakkai Zasshi 2003 ; 41 : 739-45.
53. Otero C, Illa I, Dalakas MC : Is there dermatomyositis without myositis? Neurology 1992 ; 42 : 388.
54. Sauty A, Rochat T, Schoch OD, Hamacher J, Kurt AM, Dayer JM, Nicod LP : Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies. Eur Respir J 1997 ; 10 : 2907-12.
55. Love LA, Miller FW : Noninfectious environmental agents associated with myopathies. Curr Opin Rheum 1993 ; 5 : 712-8.
56. Serratrice J, Granel B, Pache X, Disdier P, De Roux-Serratrice C, Pellissier JF, Weiller PJ : A case of polymyositis with anti-histidyl-tRNA synthetase (Jo-1) antibody syndrome following extensive vinyl chloride exposure. Clin Rheumatol 2001 ; 20 : 379-82.
57. Braun N, Arora NS, Rochester DF : Respiratory muscle and pulmonary function in polymyositis and other proximal myopathies. Thorax 1983 ; 38 : 616-23.
58. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV : Interstitial lung disease in polymyositis and dermatomyositis. Am Rev Respir Dis 1990 ; 141 : 727-33.
59. Akira M, Hara H, Sakatani M : Interstitial lung disease in association with polymyositis-dermatomyositis: long-term follow-up CT evaluation in seven patients. Radiology 1999 ; 210 : 333-8.
60. Chatté G, Boyer J : Pneumopathie interstitielle fibrosante et dermatomyosite. Rev Mal Respir 1992 ; 9 : 634-5.
61. Wallaert B, Hatron PY, Devulder B : Atteinte pulmonaire des dermato-polymyosites : intérêt du lavage bronchoalvéolaire. Presse Méd 1986 ; 5 : 1247.
62. Bunch TW, Worthington JW, Combs JJ, Ilstrup DM, Engel AG : Azathioprine with prednisone for polymyositis. A controlled, clinical trial. Ann Intern Med 1980 ; 92 : 365-9.
63. Dawson JK, Abernethy VE, Lynch MP : Effective treatment of anti Jo-1 antibody-positive polymyositis with cyclosporin. Br J Rheumatol 1997 ; 36 : 144-5.
64. Grau JM, Herrero C, Casademont J, Fernandez-Sola J, Urbano-Marquez A : Cyclosporine A as first choice therapy for dermatomyositis. J Rheumatol 1994 ; 21 : 381-2.
65. Heckmatt J, Hasson N, Saunders C, Thompson N, Peters AM, Cambridge G, Rose M, Hyde SA, Dubowitz V : Cyclosporin in juvenile dermatomyositis. Lancet 1989 ; 1 : 1063-6.
66. Chaudhry V, Cornblath DR, Griffin JW, O'Brien R, Drachman DB : Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology 2001 ; 56 : 94-6.
67. Miller FW, Leitman SF, Cronin ME, Hicks JE, Leff RL, Wesley R, Fraser DD, Dalakas M, Plotz PH : Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med 1992 ; 326 : 1380-4.
68. Dalakas MC, Illa I, Dambrosia JM : A controlled trial of high-dose intraveinous immunoglobulin infusions as treatment for dermatomyositis. N Engl J Med 1993 ; 329 : 1993-2000.
69. Johnson MA, Kwan S, Snell NJ, Nunn AJ, Darbyshire JH, Turner-Warwick M : Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax 1989 ; 44 : 280-8.
70. Tanaka F, Origuchi T, Migita K, Tominaga M, Kawakami A, Kawabe Y, Eguchi K : Successful combined therapy of cyclophosphamide and cyclosporine for acute exacerbated interstitial pneumonia associated with dermatomyositis. Intern Med 2000 ; 39 : 428-30.
71. Yoshida T, Koga H, Saitoh F, Sakamoto M, Harada M, Yoshida H, Sakisaka S, Sata M : Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis. Intern Med 1999 ; 38 : 733-738.
72. Schnabel A, Reuter M, Gross WL : Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases. Arthritis Rheum 1998 ; 41 : 1215-20.
73. Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M, Kita Y, Kawai M, Saito Y, Iwamoto I : Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. J Rheumato 1999 ; 26 : 1527-33.
74. Fujisawa T, Suda T, Nakamura Y, Enomoto N, Ide K, Toyoshima M, Uchiyama H, Tamura R, Ida M, Yagi T, Yasuda K, Genma H, Hayakawa H, Chida K, Nakamura H : Difference in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. J Rheumatol 2005 ; 32 : 58-64.